PFREUNDSCHUH PETER P.

CIK 00015858396 companiesMORRIS PLAINS, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001585839

Recent Transactions

50 trades

Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Restricted Stock Units
2025-09-16−15,900→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Common Stock
2025-09-16−77,800→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−170,000→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−63,500→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Restricted Stock Units
2025-09-16−15,900→ 0 total
Award
Y-mAbs Therapeutics, Inc.
Common Stock
2025-01-17+31,800→ 77,800 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-01-17+63,500→ 63,500 total
Award
Y-mAbs Therapeutics, Inc.
Common Stock
2024-07-12+46,000→ 46,000 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-07-12+170,000→ 170,000 total
Sale
Voyager Therapeutics, Inc.$VYGR
Common Stock
2024-02-21$7.46/sh−3,764→ 175,669 total
Award
Voyager Therapeutics, Inc.$VYGR
Common Stock
2024-02-09+30,000→ 179,433 total
Award
Voyager Therapeutics, Inc.$VYGR
Stock Option (Right to Buy)
2024-02-09+60,000→ 60,000 total
Sale
Voyager Therapeutics, Inc.$VYGR
Common Stock
2023-10-03$6.99/sh−13,567→ 149,433 total
Award
Voyager Therapeutics, Inc.$VYGR
Common Stock
2023-02-17+38,000→ 163,000 total
Award
Voyager Therapeutics, Inc.$VYGR
Stock Option (Right to Buy)
2023-02-17+76,000→ 76,000 total
Award
Voyager Therapeutics, Inc.$VYGR
Common Stock
2022-10-01+125,000→ 125,000 total
Award
Voyager Therapeutics, Inc.$VYGR
Stock Option (Right to Buy)
2022-09-19+200,000→ 200,000 total
Sale
Korro Bio, Inc.$KRRO
Common Stock
2022-02-22$3.53/sh−1,542→ 8,927 total
Sale
Korro Bio, Inc.$KRRO
Common Stock
2022-02-18$3.88/sh−1,404→ 10,469 total
Sale
Korro Bio, Inc.$KRRO
Common Stock
2022-02-17$4.20/sh−1,296→ 11,873 total
Award
Korro Bio, Inc.$KRRO
Restricted Stock Unit
2022-02-17+150,000→ 150,000 total
Sale
Korro Bio, Inc.$KRRO
Common Stock
2022-02-16$4.43/sh−1,229→ 13,169 total
Sale
Korro Bio, Inc.$KRRO
Common Stock
2022-02-15$4.33/sh−1,347→ 14,398 total
Exercise/Conversion
Korro Bio, Inc.$KRRO
Restricted Stock Unit
2022-02-14−15,000→ 15,000 total
Exercise/Conversion
Korro Bio, Inc.$KRRO
Common Stock
2022-02-14+15,000→ 15,745 total
Award
Korro Bio, Inc.$KRRO
Restricted Stock Unit
2021-04-20+30,000→ 30,000 total
Award
Korro Bio, Inc.$KRRO
Stock Option
2021-01-15+10,000→ 10,000 total
Award
Korro Bio, Inc.$KRRO
Stock Option
2020-12-02+230,000→ 230,000 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2020-10-15$21.82/sh−407→ 11,422 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2020-10-15$21.72/sh−1,017→ 10,405 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2020-10-15−2,084→ 2,082 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2020-10-15−2,000→ 4,000 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2020-10-15−833→ 1,667 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2020-10-15$21.80/sh−976→ 11,829 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2020-10-15+4,917→ 12,805 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2020-09-01$22.82/sh−509→ 7,888 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2020-09-01+1,042→ 8,397 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2020-09-01−1,042→ 4,166 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2020-07-27$23.51/sh−141→ 7,355 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2020-07-26−417→ 2,500 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2020-07-26+417→ 7,496 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2020-05-20−1,041→ 5,208 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2020-05-20+1,041→ 7,437 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2020-05-20$25.07/sh−358→ 7,079 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2020-04-27$24.35/sh−141→ 6,396 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2020-04-26+417→ 6,537 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2020-04-26−417→ 2,917 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2020-02-20$29.68/sh−360→ 6,120 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2020-02-20+1,042→ 6,480 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2020-02-20−1,042→ 6,249 total

Companies

Recent Filings

Address

C/O IMMUNOMEDICS, INC. 300 AMERICAN ROAD

MORRIS PLAINS, NJ, 07950

View on SEC.gov